ACOG

Alpha CognitionD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

earnings

Source

External coverage

Decided

2026-08-13

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

Positive commercial update for ACOG: Q1 ZUNVEYL revenue reached $3.5 million with 40% sequential growth and bottles dispensed rose 23%, though the $6.5 million net loss and lower cash balance temper the thesis. Verified against the BusinessWire release: https://www.businesswire.com/news/home/20260514615228/en/Alpha-Cognition-Inc.-Reports-First-Quarter-2026-Financial-Results-and-Provides-Operational-Update

View event details

Sentiment decomposition

30-day score

Company-55%

Macro-30%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.